Zidovudine
Contents
Description
Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HTLV-1 infection and associated conditions. While primarily developed for HIV, it has shown efficacy in managing HTLV-1-related diseases including infective dermatitis. It is often used in combination with other antiretroviral agents for HTLV-1-associated conditions.
Indications & Therapeutic Use
HIV infection, HTLV-1 infection, infective dermatitis associated with HTLV-1
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Zidovudine — GNH India
58 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Zidovudine |
| Brands | 1 brand available |
| Active Ingredient | Zidovudine |
| Drug Class | HIV infection |
| Manufacturer | ViiV Healthcare |
| Dosage Forms | Oral capsule 100mg; Oral syrup 50mg/5mL; IV infusion 10mg/mL |
| Medical Code | J05AF01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00000625 |
| Countries | 7 countries |